Abstract
Renal inflammation is the initial, healthy response to renal injury. However, prolonged inflammation promotes the fibrosis process, which leads to chronic pathology and eventually end-stage kidney disease. There are two major sources of inflammatory cells: first, bone marrow-derived leukocytes that include neutrophils, macrophages, fibrocytes and mast cells, and second, locally activated kidney cells such as mesangial cells, podocytes, tubular epithelial cells, endothelial cells and fibroblasts. These activated cells produce many profibrotic cytokines and growth factors that cause accumulation and activation of myofibroblasts, and enhance the production of the extracellular matrix. In particular, activated macrophages are key mediators that drive acute inflammation into chronic kidney disease. They produce large amounts of profibrotic factors and modify the microenvironment via a paracrine effect, and they also transdifferentiate to myofibroblasts directly, although the origin of myofibroblasts in the fibrosing kidney remains controversial. Collectively, understanding inflammatory cell functions and mechanisms during renal fibrosis is paramount to improving diagnosis and treatment of chronic kidney disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abboud HE (2012) Mesangial cell biology. Exp Cell Res 318:979–985
Allison SJ (2013) Fibrosis: the source of myofibroblasts in kidney fibrosis. Nat Rev Nephrol 9:494
Anders HJ, Ryu M (2011) Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 80:915–925
Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M et al (2004) Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J 18:534–536
Beghdadi W, Madjene LC, Claver J, Pejler G, Beaudoin L, Lehuen A, Daugas E, Blank U (2013) Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction. Kidney Int 84:317–326
Bielesz B, Sirin Y, Si H, Niranjan T, Gruenwald A et al (2010) Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 120:4040–4054
Bojakowski K, Abramczyk P, Bojakowska M, Zwolinska A, Przybylski J, Gaciong Z (2001) Fucoidan improves the renal blood flow in the early stage of renal ischemia/reperfusion injury in the rat. J Physiol Pharmacol 52:137–143
Boor P, Floege J (2011) Chronic kidney disease growth factors in renal fibrosis. Clin Exp Pharmacol Physiol 38:441–450
Boor P, Konieczny A, Villa L, Kunter U, van Roeyen CR et al (2007) PDGF-D inhibition by CR10 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant 22:1323–1331
Boor P, Ostendorf T, Floege J (2010) Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6:643–656
Boor P, Ostendorf T, Floege J (2014) PDGF and the progression of renal disease. Nephrol Dial Transplant 29(Suppl 1):i45–i54
Boor P, Babickova J, Steegh F, Hautvast P, Martin IV et al (2015) Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis. Am J Pathol 185:2132–2142
Bottinger EP, Bitzer M (2002) TGF-beta signaling in renal disease. J Am Soc Nephrol 13:2600–2610
Brahler S, Ising C, Hagmann H, Rasmus M, Hoehne M et al (2012) Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria. Am J Physiol Renal Physiol 303:F1473–F1485
Broekema M, Harmsen MC, van Luyn MJ, Koerts JA, Petersen AH et al (2007) Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J Am Soc Nephrol 18:165–175
Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71–81
Buchtler S, Grill A, Hofmarksrichter S, Stockert P, Schiechl-Brachner G et al (2018) Cellular origin and functional relevance of collagen i production in the kidney. J Am Soc Nephrol 29:1859–1873
Buhl EM, Djudjaj S, Babickova J, Klinkhammer BM, Folestad E et al (2016) The role of PDGF-D in healthy and fibrotic kidneys. Kidney Int 8:848–861
Campbell MT, Hile KL, Zhang H, Asanuma H, Vanderbrink BA et al (2011) Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res 168:e61–e69
Canaud G, Bienaime F, Viau A, Treins C, Baron W et al (2013) AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med 19:1288–1296
Cao Q, Wang Y, Harris DC (2013) Pathogenic and protective role of macrophages in kidney disease. Am J Physiol Renal Physiol 305:F3–F11
Chen G, Lin SC, Chen J, He L, Dong F et al (2011a) CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 22:1876–1886
Chen YT, Chang FC, Wu CF, Chou YH, Hsu HL et al (2011b) Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 80:1170–1181
Chen J, Chen MX, Fogo AB, Harris RC, Chen JK (2013) mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J Am Soc Nephrol 24:198–207
Chen G, Dong Z, Liu H, Liu Y, Duan S, Liu F, Chen H (2016) mTOR signaling regulates protective activity of transferred CD4+ Foxp3+ T Cells in repair of acute kidney injury. J Immunol 197:3917–3926
Cheng A, Dong Y, Zhu F, Liu Y, Hou FF, Nie J (2013) AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells. Int J Biol Sci 9:94–107
Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160:419–425
Chung AC, Lan HY (2011) Chemokines in renal injury. J Am Soc Nephrol 22:802–809
Correa-Costa M, Braga TT, Semedo P, Hayashida CY, Bechara LR et al (2011) Pivotal role of Toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis. PLoS ONE 6:e29004
Crean JK, Furlong F, Finlay D, Mitchell D, Murphy M et al (2004) Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization. FASEB J 18:1541–1543
D’Agati V, Schmidt AM (2010) RAGE and the pathogenesis of chronic kidney disease. Nat Rev Nephrol 6:352–360
Dai Y, Gu L, Yuan W, Yu Q, Ni Z et al (2013) Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis. Kidney Int 84:950–961
Danelli L, Madjene LC, Madera-Salcedo I, Gautier G, Pacreau E et al (2017) Early phase mast cell activation determines the chronic outcome of renal ischemia-reperfusion injury. J Immunol 198:2374–2382
Daroux M, Prevost G, Maillard-Lefebvre H, Gaxatte C, D’Agati VD et al (2010) Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes Metab 36:1–10
Das R, Xu S, Quan X, Nguyen TT, Kong ID et al (2014) Upregulation of mitochondrial Nox4 mediates TGF-beta-induced apoptosis in cultured mouse podocytes. Am J Physiol Renal Physiol 306:F155–F167
Das F, Ghosh-Choudhury N, Venkatesan B, Kasinath BS, Ghosh Choudhury G (2017) PDGF receptor-beta uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (alpha2) expression. Am J Physiol Renal Physiol 313:F291–F307
Deelman L, Sharma K (2009) Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens 18:85–90
Demmers MW, Baan CC, van Beelen E, Ijzermans JN, Weimar W, Rowshani AT (2013) Differential effects of activated human renal epithelial cells on T-cell migration. PLoS ONE 8:e64916
Disteldorf EM, Krebs CF, Paust HJ, Turner JE, Nouailles G et al (2015) CXCL5 drives neutrophil recruitment in TH17-mediated GN. J Am Soc Nephrol 26:55–66
Djudjaj S, Boor P (2018) Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med
Dong Y, Yang M, Zhang J, Peng X, Cheng J, Cui T, Du J (2016) Depletion of CD8+ T cells exacerbates CD4+ T cell-induced monocyte-to-fibroblast transition in renal fibrosis. J Immunol 196:1874–1881
Duffield JS, Humphreys BD (2011) Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 79:494–501
Durvasula RV, Shankland SJ (2006) The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep 8:132–138
Durvasula RV, Shankland SJ (2008) Activation of a local renin angiotensin system in podocytes by glucose. Am J Physiol Renal Physiol 294:F830–F839
Eardley KS, Kubal C, Zehnder D, Quinkler M, Lepenies J et al (2008) The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int 74:495–504
Eddy AA, Neilson EG (2006) Chronic kidney disease progression. J Am Soc Nephrol 17:2964–2966
Eitner F, Bucher E, van Roeyen C, Kunter U, Rong S et al (2008) PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J Am Soc Nephrol 19:281–289
Eremina V, Cui S, Gerber H, Ferrara N, Haigh J et al (2006) Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 17:724–735
Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W et al (1999) Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56:1455–1467
Fan JM, Huang XR, Ng YY, Nikolic-Paterson DJ, Mu W et al (2001) Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 37:820–831
Fine LG, Norman JT (2008) Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 74:867–872
Floege J, Burg M, Hugo C, Gordon KL, Van Goor H et al (1998) Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 9:792–801
Floege J, Eitner F, Alpers CE (2008) A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 19:12–23
Fogo AB (2011) The targeted podocyte. J Clin Invest 121:2142–2145
Fu S, Zhang N, Yopp AC, Chen D, Mao M et al (2004) TGF-beta induces Foxp3+ T-regulatory cells from CD4+ CD25-precursors. Am J Transplant 4:1614–1627
Fujiu K, Manabe I, Nagai R (2011) Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest 121:3425–3441
Fukuda K, Yoshitomi K, Yanagida T, Tokumoto M, Hirakata H (2001) Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 281:F513–F521
Funaba M, Ikeda T, Murakami M, Ogawa K, Nishino Y et al (2006) Transcriptional regulation of mouse mast cell protease-7 by TGF-beta. Biochem Biophys Acta 1759:166–170
Gentle ME, Shi S, Daehn I, Zhang T, Qi H et al (2013) Epithelial cell TGFbeta signaling induces acute tubular injury and interstitial inflammation. J Am Soc Nephrol 24:787–799
Gewin LS (2018) Renal fibrosis: primacy of the proximal tubule. Matrix Biol 68–69:248–262
Gewin L, Bulus N, Mernaugh G, Moeckel G, Harris RC et al (2010) TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis. J Am Soc Nephrol 21:1334–1343
Gewin L, Vadivelu S, Neelisetty S, Srichai MB, Paueksakon P et al (2012) Deleting the TGF-beta receptor attenuates acute proximal tubule injury. J Am Soc Nephrol 23:2001–2011
Gewin L, Zent R, Pozzi A (2017) Progression of chronic kidney disease: too much cellular talk causes damage. Kidney Int 91:552–560
Godel M, Hartleben B, Herbach N, Liu S, Zschiedrich S et al (2011) Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 121:2197–2209
Gomez-Guerrero C, Hernandez-Vargas P, Lopez-Franco O, Ortiz-Munoz G, Egido J (2005) Mesangial cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches. Curr Drug Targets Inflamm Allergy 4:341–351
Gorelik L, Flavell RA (2002) Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2:46–53
Grahammer F, Schell C, Huber TB (2013) The podocyte slit diaphragm–from a thin grey line to a complex signalling hub. Nat Rev Nephrol 9:587–598
Grande MT, Perez-Barriocanal F, Lopez-Novoa JM (2010) Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy. J Inflamm (Lond) 7:19
Grande MT, Sanchez-Laorden B, Lopez-Blau C, De Frutos CA, Boutet A et al (2015) Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med 21:989–997
Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K, Goerdt S (2001) Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 53:386–392
Gruber BL, Marchese MJ, Kew RR (1994) Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol 152:5860–5867
Gruden G, Perin PC, Camussi G (2005) Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diab Rev 1:27–40
Guerrot D, Dussaule JC, Kavvadas P, Boffa JJ, Chadjichristos CE, Chatziantoniou C (2012) Progression of renal fibrosis: the underestimated role of endothelial alterations. Fibrogenesis Tissue repair 5(Suppl 1):S15
Guo S, Wietecha TA, Hudkins KL, Kida Y, Spencer MW et al (2011) Macrophages are essential contributors to kidney injury in murine cryoglobulinemic membranoproliferative glomerulonephritis. Kidney Int 80:946–958
Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ (2011) c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat. Lab Invest 91:978–991
Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ (2013) Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis. Am J Physiol Renal Physiol 304:F1043–F1053
Harris RC, Neilson EG (2006) Toward a unified theory of renal progression. Annu Rev Med 57:365–380
Hathaway CK, Gasim AM, Grant R, Chang AS, Kim HS et al (2015) Low TGFbeta1 expression prevents and high expression exacerbates diabetic nephropathy in mice. Proc Natl Acad Sci USA 112:5815–5820
Hato T, El-Achkar TM, Dagher PC (2013) Sisters in arms: myeloid and tubular epithelial cells shape renal innate immunity. Am J Physiol Renal Physiol 304:F1243–F1251
He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y (2009) Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20:765–776
Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C et al (2008) Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 172:288–298
Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y et al (2007) Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117:3810–3820
Higgins DF, Kimura K, Iwano M, Haase VH (2008) Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 7:1128–1132
Hochane M, Raison D, Coquard C, Beraud C, Bethry A et al (2018) Parathyroid hormone-related protein modulates inflammation in mouse mesangial cells and blunts apoptosis by enhancing COX-2 expression. Am J Physiol Cell Physiol 314:C242–C253
Holdsworth SR, Summers SA (2008) Role of mast cells in progressive renal diseases. J Am Soc Nephrol 19:2254–2261
Huang XR, Chung AC, Wang XJ, Lai KN, Lan HY (2008a) Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. Am J Physiol Renal Physiol 295:F118–F127
Huang XR, Chung AC, Zhou L, Wang XJ, Lan HY (2008b) Latent TGF-beta1 protects against crescentic glomerulonephritis. J Am Soc Nephrol 19:233–242
Humphreys BD (2018) Mechanisms of renal fibrosis. Annu Rev Physiol 80:309–326
Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT et al (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85–97
Inoki K, Mori H, Wang J, Suzuki T, Hong S et al (2011) mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 121:2181–2196
Kanasaki K, Taduri G, Koya D (2013) Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol 4:7
Kang DH, Kanellis J, Hugo C, Truong L, Anderson S et al (2002) Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13:806–816
Kato N, Yuzawa Y, Kosugi T, Hobo A, Sato W et al (2009) The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J Am Soc Nephrol 20:1565–1576
Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV (1994) Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Nati Acad Sci USA 91:812–816
Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA et al (1996) Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97:1056–1063
Kelly KJ, Burford JL, Dominguez JH (2009) Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. Am J Physiol Renal Physiol 297:F923–F931
Kim DH, Moon SO, Jung YJ, Lee AS, Kang KP et al (2009) Mast cells decrease renal fibrosis in unilateral ureteral obstruction. Kidney Int 75:1031–1038
Kim SM, Lee SH, Lee A, Kim DJ, Kim YG et al (2015) Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression. Transl Res 166:375–383
Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K et al (2008) Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 295:F1023–F1029
Kitamoto K, Machida Y, Uchida J, Izumi Y, Shiota M et al (2009) Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. J Pharmacol Sci 111:285–292
Kitamura M, Suto TS (1997) TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 12:669–679
Kitching AR, Holdsworth SR (2011) The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol 22:235–238
Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK (2008) Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 23:842–852
Kondo S, Kagami S, Kido H, Strutz F, Muller GA, Kuroda Y (2001) Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol 12:1668–1676
Kong D, Li Y, Wang Z, Banerjee S, Ahmad A et al (2009) miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27:1712–1721
Ku CH, White KE, Dei Cas A, Hayward A, Webster Z et al (2008) Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes 57:2824–2833
Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW et al (2008) Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 294:F945–F955
Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW et al (2009) Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 24:62–72
Lan HY (2011) Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 7:1056–1067
Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC (1995) Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int 48:753–760
Lan HY, Bacher M, Yang N, Mu W, Nikolic-Paterson DJ et al (1997) The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 185:1455–1465
Laping NJ, Olson BA, Ho T, Ziyadeh FN, Albrightson CR (2000) Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells. Biochem Pharmacol 59:847–853
LeBleu VS, Kalluri R (2011) Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis. Kidney Int 80:1119–1121
LeBleu VS, Taduri G, O’Connell J, Teng Y, Cooke VG et al (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19:1047–1053
Lebrin F, Deckers M, Bertolino P, Ten Dijke P (2005) TGF-beta receptor function in the endothelium. Cardiovascular Res 65:599–608
Lee SB, Kalluri R (2010) Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl S22–S26
Li Y, Yang J, Dai C, Wu C, Liu Y (2003) Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112:503–516
Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y (2008) Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172:299–308
Li J, Qu X, Yao J, Caruana G, Ricardo SD et al (2010) Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 59:2612–2624
Lin M, Tang SC (2013) Toll-like receptors: sensing and reacting to diabetic injury in the kidney. Nephrol Dial Transplant
Lin SL, Kisseleva T, Brenner DA, Duffield JS (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173:1617–1627
Lin SL, Castano AP, Nowlin BT, Lupher ML Jr, Duffield JS (2009) Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 183:6733–6743
Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC et al (2012) Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 23:86–102
Lin JR, Zheng YJ, Zhang ZB, Shen WL, Li XD et al (2018) Suppression of endothelial-to-mesenchymal transition by SIRT (Sirtuin) 3 alleviated the development of hypertensive renal injury. Hypertension
Liu Y (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15:1–12
Liu Y (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69:213–217
Liu Y (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21:212–222
Liu Y (2011) Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7:684–696
Liu F, Chen HY, Huang XR, Chung AC, Zhou L et al (2011) C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes. Diabetologia 54:2713–2723
Liu L, Kou P, Zeng Q, Pei G, Li Y et al (2012) CD4+ T Lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis. Am J Nephrol 36:386–396
Liu P, Lassen E, Nair V, Berthier CC, Suguro M et al (2017) Transcriptomic and proteomic profiling provides insight into mesangial cell function in IgA nephropathy. J Am Soc Nephrol 28:2961–2972
Liu BC, Tang TT, Lv LL, Lan HY (2018) Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int 93:568–579
Loeffler I, Wolf G (2013) Transforming growth factor-beta and the progression of renal disease. Nephrol Dial Transplant
Lopez-Hernandez FJ, Lopez-Novoa JM (2012) Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347:141–154
Lovisa S, LeBleu VS, Tampe B, Sugimoto H, Vadnagara K et al (2015) Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med 21:998–1009
Lu J, Cao Q, Zheng D, Sun Y, Wang C et al (2013) Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int 84:745–755
Lu Y, Mei Y, Chen L, Wu L, Wang X et al (2018) The role of transcriptional factor D-site-binding protein in circadian CCL2 gene expression in anti-Thy1 nephritis. Cell Mol Immunol
Lv W, Booz GW, Wang Y, Fan F, Roman RJ (2018) Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol 820:65–76
Lyons RM, Gentry LE, Purchio AF, Moses HL (1990) Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 110:1361–1367
Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM et al (2003) Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(−/−) mice. Am J Pathol 163:1261–1273
Ma FY, Flanc RS, Tesch GH, Bennett BL, Friedman GC et al (2009a) Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat. Lab Inves 89:470–484
Ma FY, Liu J, Kitching AR, Manthey CL, Nikolic-Paterson DJ (2009b) Targeting renal macrophage accumulation via c-fms kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney. Am J Physiol Renal Physiol 296:F177–F185
Ma FY, Ikezumi Y, Nikolic-Paterson DJ (2010) Macrophage signaling pathways: a novel target in renal disease. Semin Nephrol 30:334–344
Mack M, Rosenkranz AR (2009) Basophils and mast cells in renal injury. Kidney Int 76:1142–1147
Margulis A, Nocka KH, Brennan AM, Deng B, Fleming M et al (2009) Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels: influence of cytokines, matrix metalloproteases, and serine proteases. J Immunol 183:1739–1750
Mathieson PW (2009) Update on the podocyte. Curr Opin Nephrol Hypertens 18:206–211
Mehrotra P, Patel JB, Ivancic CM, Collett JA, Basile DP (2015) Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism. Kidney Int 88:776–784
Meldrum KK, Zhang H, Hile KL, Moldower LL, Dong Z, Meldrum DR (2012) Profibrotic effect of interleukin-18 in HK-2 cells is dependent on stimulation of the Toll-like receptor 4 (TLR4) promoter and increased TLR4 expression. J Biol Chem 287:40391–40399
Meng XM, Huang XR, Chung AC, Qin W, Shao X et al (2010) Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol 21:1477–1487
Meng XM, Huang XR, Xiao J, Chen HY, Zhong X, Chung AC, Lan HY (2012a) Diverse roles of TGF-beta receptor II in renal fibrosis and inflammation in vivo and in vitro. J Pathol 227:175–188
Meng XM, Huang XR, Xiao J, Chung AC, Qin W et al (2012b) Disruption of Smad4 impairs TGF-beta/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int 81:266–279
Meng XM, Chung AC, Lan HY (2013) Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond) 124:243–254
Meng XM, Nikolic-Paterson DJ, Lan HY (2014) Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10:493–503
Meng XM, Tang PM, Li J, Lan HY (2015) TGF-beta/Smad signaling in renal fibrosis. Front Physiol 6:82
Meng XM, Nikolic-Paterson DJ, Lan HY (2016a) TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol 12:325–338
Meng XM, Wang S, Huang XR, Yang C, Xiao J et al (2016b) Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis. Cell Death Dis 7:e2495
Mezzano SA, Ruiz-Ortega M, Egido J (2001) Angiotensin II and renal fibrosis. Hypertension 38:635–638
Miyazawa S, Hotta O, Doi N, Natori Y, Nishikawa K (2004) Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. Kidney Int 65: 2228–2237
Mohamed R, Jayakumar C, Chen F, Fulton D, Stepp D et al (2016) Low-dose IL-17 therapy prevents and reverses diabetic nephropathy, metabolic syndrome, and associated organ fibrosis. J Am Soc Nephrol 27:745–765
Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL et al (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319–328
Nakagawa T, Lan HY, Zhu HJ, Kang DH, Schreiner GF, Johnson RJ (2004a) Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells. Am J Physiol Renal Physiol 287:F658–F664
Nakagawa T, Li JH, Garcia G, Mu W, Piek E et al (2004b) TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int 66:605–613
Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R (2008) Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 153:6–20
Nguan CY, Du C (2009) Renal tubular epithelial cells as immunoregulatory cells in renal allograft rejection. Transplant Rev (Orlando) 23:129–138
Niedermeier M, Reich B, Rodriguez Gomez M, Denzel A, Schmidbauer K et al (2009) CD4 +T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Nati Acad Sci USA 106:17892–17897
Nielsen R, Mollet G, Esquivel EL, Weyer K, Nielsen PK et al (2013) Increased lysosomal proteolysis counteracts protein accumulation in the proximal tubule during focal segmental glomerulosclerosis. Kidney Int 84:902–910
Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB et al (2008) The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 14:290–298
Nishida M, Hamaoka K (2008) Macrophage phenotype and renal fibrosis in obstructive nephropathy. Nephron Exp Nephrol 110:e31–e36
Ostendorf T, Rong S, Boor P, Wiedemann S, Kunter U et al (2006) Antagonism of PDGF-D by human antibody CR170 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 17:1054–1062
Ostendorf T, Eitner F, Floege J (2012) The PDGF family in renal fibrosis. Pediatr Nephrol 27:1041–1050
Paust HJ, Turner JE, Steinmetz OM, Peters A, Heymann F et al (2009) The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol 2:969–979
Peng X, Xiao Z, Zhang J, Li Y, Dong Y, Du J (2015) IL-17A produced by both gammadelta T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J Pathol 235:79–89
Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803–815
Pons M, Ali L, Beghdadi W, Danelli L, Alison M et al (2017) Mast cells and MCPT4 chymase promote renal impairment after partial ureteral obstruction. Front Immunol 8:450
Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N et al (2010) TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 21:1299–1308
Qiao X, Rao P, Zhang Y, Liu L, Pang M et al (2018) Redirecting TGF-beta signaling through the beta-catenin/Foxo complex prevents kidney fibrosis. J Am Soc Nephrol 29:557–570
Reich B, Schmidbauer K, Rodriguez Gomez M, Johannes Hermann F, Gobel N et al (2013) Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model. Kidney Int 84:78–89
Reilkoff RA, Bucala R, Herzog EL (2011) Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 11:427–435
Ricardo SD, van Goor H, Eddy AA (2008) Macrophage diversity in renal injury and repair. J Clin Invest 118:3522–3530
Robertson H, Ali S, McDonnell BJ, Burt AD, Kirby JA (2004) Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 15:390–397
Rutkowski JM, Wang ZV, Park AS, Zhang J, Zhang D et al (2013) Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol 24:268–282
Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K, Kaneko S (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR182 signaling regulates fibrocytes in renal fibrosis. Proc Nati Acad Sci USA 103:14098–14103
Sam R, Wanna L, Gudehithlu KP, Garber SL, Dunea G et al (2006) Glomerular epithelial cells transform to myofibroblasts: early but not late removal of TGF-beta1 reverses transformation. Transl Res 148:142–148
Scandiuzzi L, Beghdadi W, Daugas E, Abrink M, Tiwari N et al (2010) Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis. J Immunol 185:624–633
Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P et al (2001) Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108:807–816
Schlondorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20:1179–1187
Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC (2003) TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284:F243–F252
Schnoor M, Cullen P, Lorkowski J, Stolle K, Robenek H et al (2008) Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J Immunol 180:5707–5719
Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K et al (2016) Podocyte-specific deletion of yes-associated protein causes FSGS and progressive renal failure. J Am Soc Nephrol 27:216–226
Shanmugam N, Figarola JL, Li Y, Swiderski PM, Rahbar S, Natarajan R (2008) Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes 57:879–888
Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D (2008) Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 83:1323–1333
Sharma S, Sirin Y, Susztak K (2011) The story of Notch and chronic kidney disease. Curr Opin Nephrol Hypertens 20:56–61
Shi XY, Hou FF, Niu HX, Wang GB, Xie D (2008) Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 149:1829–1839
Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O et al (1999) Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312–315
Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122:787–795
Siddiqi FS, Advani A (2013) Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes. Diabetes 62:3647–3655
Strutz F, Zeisberg M (2006) Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17:2992–2998
Summers SA, Gan PY, Dewage L, Ma FT, Ooi JD et al (2012) Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. Kidney Int 82:676–685
Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M et al (1996) Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148:1169–1180
Taniguchi K, Xia L, Goldberg HJ, Lee KW, Shah A et al (2013) Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. Diabetes 62:3874–3886
Tapmeier TT, Fearn A, Brown K, Chowdhury P, Sacks SH et al (2010) Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int 78:351–362
Tipping PG, Holdsworth SR (2006) T cells in crescentic glomerulonephritis. J Am Soc Nephrol 17:1253–1263
Turner JE, Paust HJ, Steinmetz OM, Panzer U (2010) The Th17 immune response in renal inflammation. Kidney Int 77:1070–1075
Ueno T, Kobayashi N, Nakayama M, Takashima Y, Ohse T et al (2013) Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int 83:1065–1075
van Roeyen CR, Eitner F, Boor P, Moeller MJ, Raffetseder U et al (2011) Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D. Kidney Int 80:1292–1305
Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK (2010) Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298:F1078–F1094
Vernon MA, Mylonas KJ, Hughes J (2010) Macrophages and renal fibrosis. Semin Nephrol 30:302–317
Veron D, Reidy KJ, Bertuccio C, Teichman J, Villegas G et al (2010) Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int 77:989–999
Veron D, Bertuccio CA, Marlier A, Reidy K, Garcia AM et al (2011) Podocyte vascular endothelial growth factor (Vegf(1)(6)(4)) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes. Diabetologia 54:1227–1241
Wada T, Sakai N, Matsushima K, Kaneko S (2007) Fibrocytes: a new insight into kidney fibrosis. Kidney Int 72:269–273
Wang YM, Zhang GY, Wang Y, Hu M, Wu H et al (2006) Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. J Am Soc Nephrol 17:697–706
Wang Y, Wang YP, Zheng G, Lee VW, Ouyang L et al (2007) Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 72:290–299
Wang Y, Deb DK, Zhang Z, Sun T, Liu W et al (2012) Vitamin D receptor signaling in podocytes protects against diabetic nephropathy. J Am Soc Nephrol 23:1977–1986
Wang H, Wang J, Bai Y, Li J, Li L, Dong Y (2016a) CD11c(+) CD8(+) T Cells Reduce Renal Fibrosis Following Ureteric Obstruction by Inducing Fibroblast Apoptosis. Int J Mol Sci 18
Wang S, Meng XM, Ng YY, Ma FY, Zhou S et al (2016b) TGF-beta/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis. Oncotarget 7:8809–8822
Wang X, Yao B, Wang Y, Fan X, Wang S et al (2017a) Macrophage cyclooxygenase-2 protects against development of diabetic nephropathy. Diabetes 66:494–504
Wang YY, Jiang H, Pan J, Huang XR, Wang YC et al (2017b) Macrophage-to- myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury. J Am Soc Nephrol 28:2053–2067
Wasse H, Naqvi N, Husain A (2012) Impact of mast cell chymase on renal disease progression. Curr Hypertens Rev 8:15–23
Wilkinson L, Gilbert T, Sipos A, Toma I, Pennisi DJ et al (2009) Loss of renal microvascular integrity in postnatal Crim1 hypomorphic transgenic mice. Kidney Int 76:1161–1171
Wynes MW, Frankel SK, Riches DW (2004) IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal. J Leukoc Biol 76:1019–1027
Xavier S, Vasko R, Matsumoto K, Zullo JA, Chen R et al (2015) Curtailing endothelial TGF-beta signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. J Am Soc Nephrol 26:817–829
Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K et al (2009) Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis 54:653–664
Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R et al (1998a) Local macrophage proliferation in human glomerulonephritis. Kidney Int 54:143–151
Yang N, Wu LL, Nikolic-Paterson DJ, Ng YY, Yang WC et al (1998b) Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant 13:1967–1974
Yang J, Dai C, Liu Y (2002) Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 13:2464–2477
Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16:535–543, 531p following 143
Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T et al (2008) Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int 73:446–455
You H, Gao T, Cooper TK, Brian Reeves W, Awad AS (2013) Macrophages directly mediate diabetic renal injury. Am J Physiol Renal Physiol 305:F1719–F1727
You H, Gao T, Raup-Konsavage WM, Cooper TK, Bronson SK et al (2017) Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice. Kidney Int 91:671–682
Zeisberg M, Neilson EG (2010) Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21:1819–1834
Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19:2282–2287
Zeng F, Kloepfer LA, Finney C, Diedrich A, Harris RC (2016) Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion. Am J Physiol Renal Physiol 311:F695–F707
Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB (2008) TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 19:923–932
Zhang F, Tsai S, Kato K, Yamanouchi D, Wang C et al (2009) Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J Biol Chem 284:17564–17574
Zheng G, Wang Y, Mahajan D, Qin X, Alexander SI, Harris DC (2005) The role of tubulointerstitial inflammation. Kidney Int Suppl S96–S100
Zhou LL, Hou FF, Wang GB, Yang F, Xie D, Wang YP, Tian JW (2009) Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int 76:1148–1160
Acknowledgements
This laboratory is supported by grants from National Natural Science Foundation of China (National Science Foundation of China 81300580 and 81570623) and by Science and Technological Fund of Anhui Province for Outstanding Youth of China (Grant number: 1608085J07).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Meng, XM. (2019). Inflammatory Mediators and Renal Fibrosis. In: Liu, BC., Lan, HY., Lv, LL. (eds) Renal Fibrosis: Mechanisms and Therapies. Advances in Experimental Medicine and Biology, vol 1165. Springer, Singapore. https://doi.org/10.1007/978-981-13-8871-2_18
Download citation
DOI: https://doi.org/10.1007/978-981-13-8871-2_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8870-5
Online ISBN: 978-981-13-8871-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)